1-3 of 3
Virgil McKie, MD
Close
Sort by
Journal Articles

Long Term Outcome of Patients Enrolled Into STOP and STOP II Trials: A Single Center Experience

Gloria Sayer, Latanya Bowman, RN, Betsy Clair, Austin Cail, Beverly Blanchard, Kavita Natrajan, MBBS, Virgil McKie, MD, Robert J. Adams, MD, MS, Abdullah Kutlar, MD
Journal: Blood
Blood (2012) 120 (21): 3219.
https://doi.org/10.1182/blood.V120.21.3219.3219
Published: 2012
Journal Articles

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Abdullah Kutlar, MD, Donald Brambilla, PhD, Betsy Clair, Anne Haghighat, Sule Bakanay, MD, Gaye Adams, MD, Ferdane Kutlar, MD, Virgil McKie, MD, Beatrice Files, MD, Gerald Woods, MD, Melanie Kirby, MD, Elliott Vichinsky, MD, Clark Brown, MD, Charles Scher, MD, Robert Adams, MD
Journal: Blood
Blood (2007) 110 (11): 429.
https://doi.org/10.1182/blood.V110.11.429.429
Published: 2007
Journal Articles

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Tom Adamkiewicz, MD, Miguel R. Abboud, MD, Julio C. Barredo, MD, Melanie Kirby-Allen, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Rathi V. Iyer, MD, Virgil McKie, MD, Gerald Milton Woods, MD, Abdullah Kutlar, MD, Carole Paley, MD, Jessica Peterson, Elizabeth Rackoff, Manuela Merelles-Pulcini, Elizabeth Dackiw, Kristin Stegenga, Nadine Odo, Mimi Lou, Robert J. Adams, MD
Journal: Blood
Blood (2006) 108 (11): 791.
https://doi.org/10.1182/blood.V108.11.791.791
Published: 2006